1 |
Shimada K, Katagiri D, Kato A, Nunose N, Sato M, Katayama Y, Terakawa K, Niikura T, Sakamoto E, Yoshizaki Y, Suzuki M, Fukaya T, Tamaki T, Takano H. A case of severe generalized pustular psoriasis successfully treated with IL-17A monoclonal antibody and granulocyte removal therapy. Ren Replace Ther 2022;8. [DOI: 10.1186/s41100-022-00439-y] [Reference Citation Analysis]
|
2 |
Noguchi Y, Shimazu K, Totani T, Komura K, Tanaka A. Comparison of adsorption efficiency of leukocytes in single needle GMA with or without PSL treatment in patients with active ulcerative colitis. Transfus Apher Sci 2022;:103581. [PMID: 36167614 DOI: 10.1016/j.transci.2022.103581] [Reference Citation Analysis]
|
3 |
Bamias G, Zampeli E, Domènech E. Targeting neutrophils in inflammatory bowel disease: revisiting the role of adsorptive granulocyte and monocyte apheresis. Expert Rev Gastroenterol Hepatol 2022;16:721-35. [PMID: 35833363 DOI: 10.1080/17474124.2022.2100759] [Reference Citation Analysis]
|
4 |
Kashiwagi N, Saito F, Maegawa H, Kaneda K. Granulocyte and monocyte adsorptive apheresis induces apoptosis of neutrophils and release of a novel chemoattractant for desensitization of interleukin-8 response - In vitro and in vivo results. Cytokine 2021;139:155410. [PMID: 33395614 DOI: 10.1016/j.cyto.2020.155410] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
|
5 |
Nishise S, Takeda Y, Abe Y, Sasaki Y, Saitoh S, Nara H, Asao H, Ueno Y. Physiological heating augments the anti-inflammatory reactions during granulocyte/monocyte apheresis: A in vitro study. Ther Apher Dial 2021;25:671-80. [PMID: 33067913 DOI: 10.1111/1744-9987.13600] [Reference Citation Analysis]
|
6 |
Yokoyama Y, Sawada K, Aoyama N, Yoshimura N, Sako M, Hirai F, Kashiwagi N, Suzuki Y. Efficacy of Granulocyte and Monocyte Adsorptive Apheresis in Patients With Inflammatory Bowel Disease Showing Lost Response to Infliximab. J Crohns Colitis 2020;14:1264-73. [PMID: 32166331 DOI: 10.1093/ecco-jcc/jjaa051] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 2.7] [Reference Citation Analysis]
|
7 |
Okuno T, Yoshida Y, Takaki Y, Araki Y, Inoue H, Soejima K, Okado Y, Yoshida K, Imamura H, Hagiwara S, Matsumoto S, Kitano T. Observation of Granulocyte Adsorption in Adacolumn Cellulose Acetate Beads after Granulocytapheresis. Ther Apher Dial 2019;23:210-6. [PMID: 31025504 DOI: 10.1111/1744-9987.12815] [Reference Citation Analysis]
|
8 |
Saniabadi AR, Tanaka T, Yamamoto T, Kruis W, Sacco R. Granulomonocytapheresis as a cell-dependent treatment option for patients with inflammatory bowel disease: Concepts and clinical features for better therapeutic outcomes. J Clin Apher. 2019;34:51-60. [PMID: 30407662 DOI: 10.1002/jca.21670] [Cited by in Crossref: 13] [Cited by in F6Publishing: 16] [Article Influence: 2.6] [Reference Citation Analysis]
|
9 |
Kanekura T. Clinical and immunological effects of adsorptive myeloid lineage leukocyte apheresis in patients with immune disorders. J Dermatol. 2018;45:943-950. [PMID: 29782055 DOI: 10.1111/1346-8138.14471] [Cited by in Crossref: 10] [Cited by in F6Publishing: 12] [Article Influence: 2.0] [Reference Citation Analysis]
|
10 |
Nishise S, Takeda Y, Nara H, Abe Y, Sasaki Y, Asao H, Ueno Y. Adsorption of Soluble Immunoglobulin-Type Adhesion Molecules to Cellulose Acetate Beads. Ther Apher Dial. 2018;22:261-265. [PMID: 29745046 DOI: 10.1111/1744-9987.12693] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
|
11 |
Sakanoue M, Higashi Y, Kanekura T. Inhibition of Inflammatory Cytokines and Induction of Myeloid-Derived Suppressor Cells by the Effects of Granulocyte and Monocyte Adsorption Apheresis. Ther Apher Dial. 2017;21:628-634. [PMID: 28941055 DOI: 10.1111/1744-9987.12580] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
|
12 |
Kanekura T, Seishima M, Honma M, Etou T, Eto H, Okuma K, Okubo Y, Yamaguchi Y, Kambara T, Mabuchi T, Suga Y, Morita A, Yamanishi K, Tsuruta D, Itoh K, Yamaji K, Ikeda S. Therapeutic depletion of myeloid lineage leukocytes by adsorptive apheresis for psoriatic arthritis: Efficacy of a non-drug intervention for patients refractory to pharmacologics. J Dermatol 2017;44:1353-9. [DOI: 10.1111/1346-8138.13975] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 2.7] [Reference Citation Analysis]
|
13 |
Morabito V, Novelli S, Poli L, Ferretti G, Ruberto F, Pugliese F, Pretagostini R, Berloco PB, Rossi M. Adacolumn Granulocyte-Apheresis for Alcoholic Hepatitis: Preliminary Study. Transplant Proc. 2016;48:352-358. [PMID: 27109954 DOI: 10.1016/j.transproceed.2015.12.055] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
|
14 |
Hara Y, Shimomura Y, Nakamura T, Kuriyama N, Yamashita C, Kato Y, Miyasho T, Sakai T, Yamada S, Moriyama K, Nishida O. Novel Blood Purification System for Regulating Excessive Immune Reactions in Severe Sepsis and Septic Shock: An Ex Vivo Pilot Study. Ther Apher Dial 2015;19:308-15. [PMID: 26386217 DOI: 10.1111/1744-9987.12338] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.3] [Reference Citation Analysis]
|
15 |
Contini P, Negrini S, Bodini G, Trucchi C, Ubezio G, Strada P, Savarino V, Ghio M. Granulocytes and monocytes apheresis induces upregulation of TGFβ1 in patients with active ulcerative colitis: A possible involvement of soluble HLA-I. J Clin Apher 2017;32:49-55. [PMID: 27080173 DOI: 10.1002/jca.21466] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
|
16 |
Kuwaki K, Mitsuyama K, Kaida H, Takedatsu H, Yoshioka S, Yamasaki H, Yamauchi R, Fukunaga S, Abe T, Tsuruta O. A longitudinal study of FDG-PET in Crohn disease patients receiving granulocyte/monocyte apheresis therapy. Cytotherapy. 2016;18:291-299. [PMID: 26700210 DOI: 10.1016/j.jcyt.2015.10.010] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.1] [Reference Citation Analysis]
|
17 |
Fujisawa T, Suzuki S, Mizutani Y, Doi T, Yoshida S, Ogura S, Seishima M. Granulocyte and Monocyte Adsorption Apheresis for Generalized Pustular Psoriasis: Therapeutic Outcomes in Three Refractory Patients: Granulocytapheresis for GPP. Ther Apher Dial 2015;19:336-41. [DOI: 10.1111/1744-9987.12342] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 2.0] [Reference Citation Analysis]
|
18 |
Ansary MM, Ishihara S, Oka A, Kusunoki R, Oshima N, Yuki T, Kawashima K, Maegawa H, Kashiwagi N, Kinoshita Y. Apoptotic cells ameliorate chronic intestinal inflammation by enhancing regulatory B-cell function. Inflamm Bowel Dis 2014;20:2308-20. [PMID: 25358066 DOI: 10.1097/MIB.0000000000000240] [Cited by in Crossref: 25] [Cited by in F6Publishing: 25] [Article Influence: 2.8] [Reference Citation Analysis]
|
19 |
Saniabadi AR, Tanaka T, Ohmori T, Sawada K, Yamamoto T, Hanai H. Treating inflammatory bowel disease by adsorptive leucocytapheresis: A desire to treat without drugs. World J Gastroenterol 2014; 20(29): 9699-9715 [PMID: 25110409 DOI: 10.3748/wjg.v20.i29.9699] [Cited by in CrossRef: 54] [Cited by in F6Publishing: 57] [Article Influence: 6.0] [Reference Citation Analysis]
|
20 |
Takeda Y, Nara H, Araki A, Asao H. Human Peripheral Neutrophils Express Functional IL-21 Receptors. Inflammation 2014;37:1521-32. [DOI: 10.1007/s10753-014-9879-0] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 1.4] [Reference Citation Analysis]
|
21 |
Hidaka M, Wakabayashi I, Takeda Y, Fukuzawa K. Vitamin D₃ derivatives increase soluble CD14 release through ERK1/2 activation and decrease IL-8 production in intestinal epithelial cells. Eur J Pharmacol 2013;721:305-12. [PMID: 24060240 DOI: 10.1016/j.ejphar.2013.09.014] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 1.1] [Reference Citation Analysis]
|
22 |
Bamba T, Yamamoto T, Umegae S, Matsumoto K. Effects of preoperative leukocytapheresis on inflammatory cytokines following surgery for ulcerative colitis: a prospective randomized study. J Clin Apher. 2014;29:107-112. [PMID: 24000140 DOI: 10.1002/jca.21299] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 0.5] [Reference Citation Analysis]
|
23 |
Ikeda S, Takahashi H, Suga Y, Eto H, Etoh T, Okuma K, Takahashi K, Kanbara T, Seishima M, Morita A, Imai Y, Kanekura T. Therapeutic depletion of myeloid lineage leukocytes in patients with generalized pustular psoriasis indicates a major role for neutrophils in the immunopathogenesis of psoriasis. J Am Acad Dermatol 2013;68:609-17. [PMID: 23332516 DOI: 10.1016/j.jaad.2012.09.037] [Cited by in Crossref: 83] [Cited by in F6Publishing: 84] [Article Influence: 8.3] [Reference Citation Analysis]
|
24 |
Takeda Y, Kaneda K, Jimma F, Shiobara N, Hidaka M, Saniabadi AR, Wakabayashi I. Inhibition of CXCL10 release by monomeric C3bi and C4b. Clin Exp Immunol 2012;167:149-57. [PMID: 22132894 DOI: 10.1111/j.1365-2249.2011.04490.x] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
|
25 |
Hidaka M, Fukuzawa K. Down-Modulation of Toll-Like Receptor 2 Expression on Granulocytes and Suppression of Interleukin-8 Production Due To In Vitro Treatment With Cellulose Acetate Beads: CA Beads Effect on Granulocytes In Vitro. Therapeutic Apheresis and Dialysis 2011;15:572-8. [DOI: 10.1111/j.1744-9987.2011.00992.x] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
|
26 |
Horie Y, Yamagishi Y, Ebinuma H, Hibi T. Therapeutic strategies for severe alcoholic hepatitis. Clin Res Hepatol Gastroenterol 2011;35:738-44. [PMID: 21840788 DOI: 10.1016/j.clinre.2011.07.005] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 1.0] [Reference Citation Analysis]
|
27 |
Naito Y, Takagi T, Yoshikawa T. Neutrophil-dependent oxidative stress in ulcerative colitis. J Clin Biochem Nutr 2007;41:18-26. [PMID: 18392100 DOI: 10.3164/jcbn.2007003] [Cited by in Crossref: 73] [Cited by in F6Publishing: 77] [Article Influence: 6.1] [Reference Citation Analysis]
|
28 |
Takeda Y, Ohba M, Ueno M, Saniabadi AR, Wakabayashi I. Cellulose Acetate Beads Activate the Complement System but Inactivate the Anaphylatoxins Generated: COMPLEMENT ACTIVATION AND ANAPHYLATOXIN INACTIVATION. Artificial Organs 2010;34:1144-9. [DOI: 10.1111/j.1525-1594.2009.00995.x] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 0.6] [Reference Citation Analysis]
|
29 |
Hanai H, Takeda Y, Eberhardson M, Gruber R, Saniabadi AR, Winqvist O, Lofberg R. The mode of actions of the Adacolumn therapeutic leucocytapheresis in patients with inflammatory bowel disease: a concise review. Clin Exp Immunol. 2011;163:50-58. [PMID: 21078086 DOI: 10.1111/j.1365-2249.2010.04279.x] [Cited by in Crossref: 65] [Cited by in F6Publishing: 72] [Article Influence: 5.0] [Reference Citation Analysis]
|
30 |
Hanai H, Takeda Y, Eberhardson M, Gruber R, Saniabadi AR, Winqvist O, Lofberg R. The mode of actions of the Adacolumn therapeutic leucocytapheresis in patients with inflammatory bowel disease: a concise review. Clin Exp Immunol 2011;163:50-8. [PMID: 21078086 DOI: 10.1111/j.1365-2249.2010.04279.x] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
|
31 |
Jimma F, Takeda Y, Kaneda K, Wakabayashi I. Induction of Foxp3 expression in T cells by cellulose acetate beads in vitro. J Clin Apheresis 2010;25:216-22. [DOI: 10.1002/jca.20243] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
|
32 |
Takeda S, Sato T, Katsuno T, Nakagawa T, Noguchi Y, Yokosuka O, Saito Y. Adsorptive depletion of alpha4 integrin(hi)- and CX3CR1hi-expressing proinflammatory monocytes in patients with ulcerative colitis. Dig Dis Sci 2010;55:1886-95. [PMID: 19908144 DOI: 10.1007/s10620-009-0974-2] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.4] [Reference Citation Analysis]
|
33 |
Cabriada JL, Ibargoyen N, Hernández A, Bernal A, Castiella A. Sustained remission after steroids and leukocytapheresis induced response in steroid-dependent ulcerative colitis: results at 1 year. Dig Liver Dis 2010;42:432-5. [PMID: 19833566 DOI: 10.1016/j.dld.2009.09.001] [Cited by in Crossref: 13] [Cited by in F6Publishing: 15] [Article Influence: 1.0] [Reference Citation Analysis]
|
34 |
Morris JM, Dickson S, Neilson M, Hodgins P, Forrest EH. Granulocytapheresis in the treatment of severe alcoholic hepatitis: a case series. Eur J Gastroenterol Hepatol 2010;22:457-60. [PMID: 19855284 DOI: 10.1097/MEG.0b013e328332a360] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 1.2] [Reference Citation Analysis]
|
35 |
Nishise S, Takeda Y, Fujishima S, Orii T, Sato T, Sasaki Y, Nishise Y, Takeda H, Kawata S. Release of Interleukin-1 Receptor Antagonist by Combining a Leukocyte Adsorption Carrier With Ulinastatin: IL-1ra Release by Ulinastatin. Therapeutic Apheresis and Dialysis 2010;14:386-91. [DOI: 10.1111/j.1744-9987.2010.00820.x] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.5] [Reference Citation Analysis]
|
36 |
Nishise S, Takeda Y, Nishise Y, Fujishima S, Orii T, Otake S, Sato T, Sasaki Y, Takeda H, Kawata S. Biological Effect of Anaphylatoxin C5a on the Generation of Anti-inflammatory Substances in Leukocyte Adsorption. Therapeutic Apheresis and Dialysis 2009;13:509-14. [DOI: 10.1111/j.1744-9987.2009.00779.x] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 0.8] [Reference Citation Analysis]
|
37 |
Hibi T, Sameshima Y, Sekiguchi Y, Hisatome Y, Maruyama F, Moriwaki K, Shima C, Saniabadi AR, Matsumoto T. Treating ulcerative colitis by Adacolumn therapeutic leucocytapheresis: clinical efficacy and safety based on surveillance of 656 patients in 53 centres in Japan. Dig Liver Dis 2009;41:570-7. [PMID: 19211314 DOI: 10.1016/j.dld.2008.11.020] [Cited by in Crossref: 50] [Cited by in F6Publishing: 51] [Article Influence: 3.6] [Reference Citation Analysis]
|
38 |
Iwakami Y, Sakuraba A, Sato T, Takada Y, Izumiya M, Ichikawa H, Hibi T. Granulocyte and Monocyte Adsorption Apheresis Therapy Modulates Monocyte-Derived Dendritic Cell Function in Patients With Ulcerative Colitis: GMA Modulates moDC Function. Therapeutic Apheresis and Dialysis 2009;13:138-46. [DOI: 10.1111/j.1744-9987.2009.00668.x] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 0.9] [Reference Citation Analysis]
|
39 |
Tozawa K, Fukunaga K, Kamikozuru K, Ohnishi K, Hida N, Ohda Y, Kusaka T, Yoshida K, Jinno Y, Nagase K, Nakamura S, Miwa H, Matsumoto T. Hyperthermic stimulation of blood increases the immunological effects of granulocyte and monocyte adsorption in vitro: Relevance to extracorporeal immunomodulation. Transfusion and Apheresis Science 2008;39:129-35. [DOI: 10.1016/j.transci.2008.07.012] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
|
40 |
Takeda H, Suzuki Y, Takeda Y, Nishise S, Fukui T, Fujishima S, Orii T, Otake S, Sato T, Suzuki K, Nakamuara Y, Kawata S. A multi center study of granulocyte and monocyte adsorption apheresis therapy for ulcerative colitis-clinical efficacy and production of interleukin-1 receptor antagonist. J Clin Apher 2008;23:105-10. [PMID: 18449931 DOI: 10.1002/jca.20164] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.3] [Reference Citation Analysis]
|
41 |
Hanai H. Leucocytapheresis for inflammatory bowel disease in the era of biologic therapy. Eur J Gastroenterol Hepatol 2008;20:596-600. [PMID: 18679059 DOI: 10.1097/MEG.0b013e3282f5e9f3] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 0.7] [Reference Citation Analysis]
|
42 |
Seishima M, Mizutani Y, Shibuya Y, Nagasawa C, Aoki T. Efficacy of granulocyte and monocyte adsorption apheresis for pustular psoriasis. Ther Apher Dial 2008;12:13-8. [PMID: 18257807 DOI: 10.1111/j.1744-9987.2007.00536.x] [Cited by in Crossref: 12] [Cited by in F6Publishing: 15] [Article Influence: 0.8] [Reference Citation Analysis]
|
43 |
Martín de Carpi J, Vilar P, Prieto G, García Novo MD, Ribes C, Varea V. Safety and efficacy of granulocyte and monocyte adsorption apheresis in paediatric inflammatory bowel disease: a prospective pilot study. J Pediatr Gastroenterol Nutr 2008;46:386-91. [PMID: 18367949 DOI: 10.1097/MPG.0b013e31815604e5] [Cited by in Crossref: 24] [Cited by in F6Publishing: 23] [Article Influence: 1.6] [Reference Citation Analysis]
|
44 |
Saniabadi AR, Hanai H, Fukunaga K, Sawada K, Shima C, Bjarnason I, Lofberg R. Therapeutic leukocytapheresis for inflammatory bowel disease. Transfus Apher Sci. 2007;37:191-200. [PMID: 17974479 DOI: 10.1016/j.transci.2007.08.003] [Cited by in Crossref: 66] [Cited by in F6Publishing: 68] [Article Influence: 4.1] [Reference Citation Analysis]
|
45 |
Naito Y, Takagi T, Yoshikawa T. Molecular fingerprints of neutrophil-dependent oxidative stress in inflammatory bowel disease. J Gastroenterol 2007;42:787-98. [PMID: 17940831 DOI: 10.1007/s00535-007-2096-y] [Cited by in Crossref: 82] [Cited by in F6Publishing: 86] [Article Influence: 5.1] [Reference Citation Analysis]
|
46 |
DeAngelis RA, Markiewski MM, Lambris JD. Liver regeneration: a link to inflammation through complement. Adv Exp Med Biol. 2006;586:17-34. [PMID: 16893062 DOI: 10.1007/0-387-34134-X_2] [Cited by in Crossref: 17] [Cited by in F6Publishing: 19] [Article Influence: 1.1] [Reference Citation Analysis]
|
47 |
Hanai H. Positions of selective leukocytapheresis in the medical therapy of ulcerative colitis. World J Gastroenterol 2006; 12(47): 7568-7577 [PMID: 17171783 DOI: 10.3748/wjg.v12.i47.7568] [Cited by in CrossRef: 33] [Cited by in F6Publishing: 38] [Article Influence: 1.9] [Reference Citation Analysis]
|
48 |
Uchida K, Inoue M, Otake K, Yoshiyama S, Toiyama Y, Hiro J, Araki T, Miki C, Kusunoki M. The significance of serum hepatocyte growth factor levels in planning follow-up of postoperative jaundice-free patients with biliary atresia. J Pediatr Surg 2006;41:1657-62. [PMID: 17011264 DOI: 10.1016/j.jpedsurg.2006.05.058] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 0.5] [Reference Citation Analysis]
|
49 |
Sakimura K, Omori T, Iwashita E, Yoshida T, Tsuzuki Y, Fujimori K, Konishi F, Yoshida Y, Anzai H, Suzuki H, Sugawara S, Takeda Y, Hiraishi K, Saniabadi AR, Ide T, Miura S, Ota S. Clinical response is associated with elevated plasma interleukin-1 receptor antagonist during selective granulocyte and monocyte apheresis in patients with ulcerative colitis. Dig Dis Sci 2006;51:1525-31. [PMID: 16902810 DOI: 10.1007/s10620-005-9012-1] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 0.9] [Reference Citation Analysis]
|
50 |
Kanekura T, Hiraishi K, Kawahara K, Maruyama I, Kanzaki T. Granulocyte and Monocyte Adsorption Apheresis (GCAP) for Refractory Skin Diseases Caused by Activated Neutrophils and Psoriatic Arthritis: Evidence that GCAP Removes Mac-1-Expressing Neutrophils. Therapher Dial 2006;10:247-56. [DOI: 10.1111/j.1744-9987.2006.00369.x] [Cited by in Crossref: 33] [Cited by in F6Publishing: 35] [Article Influence: 1.9] [Reference Citation Analysis]
|
51 |
Nishise S, Takeda Y, Takeda H, Ishihama K, Fukui T, Kawata S. Complement activation is involved in biological responses to leukocyte adsorptive apheresis. Dig Dis Sci 2006;51:934-41. [PMID: 16642423 DOI: 10.1007/s10620-005-9050-8] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 0.8] [Reference Citation Analysis]
|
52 |
Yamamoto T, Umegae S, Matsumoto K. Safety and clinical efficacy of granulocyte and monocyte adsorptive apheresis therapy for ulcerative colitis. World J Gastroenterol 2006; 12(4): 520-525 [PMID: 16489663 DOI: 10.3748/wjg.v12.i4.520] [Cited by in CrossRef: 25] [Cited by in F6Publishing: 32] [Article Influence: 1.5] [Reference Citation Analysis]
|
53 |
Namba K, Sonoda K, Kitamei H, Shiratori K, Ariyama A, Iwabuchi K, Onoé K, Saniabadi AR, Inaba S, Ishibashi T, Ohno S. Granulocytapheresis in patients with refractory ocular Behcet's disease. J Clin Apheresis 2006;21:121-8. [DOI: 10.1002/jca.20076] [Cited by in Crossref: 18] [Cited by in F6Publishing: 19] [Article Influence: 1.1] [Reference Citation Analysis]
|
54 |
Saniabadi AR, Hanai H, Suzuki Y, Ohmori T, Sawada K, Yoshimura N, Saito Y, Takeda Y, Umemura K, Kondo K, Ikeda Y, Fukunaga K, Nakashima M, Beretta A, Bjarnason I, Lofberg R. Adacolumn for selective leukocytapheresis as a non-pharmacological treatment for patients with disorders of the immune system: an adjunct or an alternative to drug therapy? J Clin Apher. 2005;20:171-184. [PMID: 15892107 DOI: 10.1002/jca.20046] [Cited by in Crossref: 78] [Cited by in F6Publishing: 86] [Article Influence: 4.3] [Reference Citation Analysis]
|
55 |
Sanmartí R, Marsal S, Valverde J, Casado E, Lafuente R, Kashiwagi N, Rodriguez-cros J, Erra A, Reina D, Gratacós J. Adsorptive granulocyte/monocyte apheresis for the treatment of refractory rheumatoid arthritis: an open pilot multicentre trial. Rheumatology 2005;44:1140-4. [DOI: 10.1093/rheumatology/keh701] [Cited by in Crossref: 16] [Cited by in F6Publishing: 18] [Article Influence: 0.9] [Reference Citation Analysis]
|